BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30308532)

  • 1. Integrating Cervical Cancer Screening Into Safer Conception Services to Improve Women's Health Outcomes: A Pilot Study at a Primary Care Clinic in South Africa.
    Davies NECG; Chersich M; Mullick S; Naidoo N; Makhoba N; Rees H; Schwartz SR
    Sex Transm Dis; 2019 Feb; 46(2):91-97. PubMed ID: 30308532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa.
    Lince-Deroche N; Phiri J; Michelow P; Smith JS; Firnhaber C
    PLoS One; 2015; 10(11):e0141969. PubMed ID: 26569487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer risk and impact of Pap-based screening in HIV-positive women on antiretroviral therapy in Johannesburg, South Africa.
    Rohner E; Sengayi M; Goeieman B; Michelow P; Firnhaber C; Maskew M; Bohlius J
    Int J Cancer; 2017 Aug; 141(3):488-496. PubMed ID: 28440019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women's experiences with cervical cancer screening in a colposcopy referral clinic in Cape Town, South Africa: a qualitative analysis.
    Momberg M; Botha MH; Van der Merwe FH; Moodley J
    BMJ Open; 2017 Feb; 7(2):e013914. PubMed ID: 28213603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilisation and outcomes of cervical cancer prevention services among HIV-infected women in Cape Town.
    Batra P; Kuhn L; Denny L
    S Afr Med J; 2010 Jan; 100(1):39-44. PubMed ID: 20429487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subfertility among HIV-affected couples in a safer conception cohort in South Africa.
    Iyer JR; Van Rie A; Haberlen SA; Mudavanhu M; Mutunga L; Bassett J; Schwartz SR
    Am J Obstet Gynecol; 2019 Jul; 221(1):48.e1-48.e18. PubMed ID: 30807762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women's triage and management preferences for cervical cytologic reports demonstrating atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions.
    Ferris DG; Kriegel D; Cote L; Litaker M; Woodward L
    Arch Fam Med; 1997; 6(4):348-53. PubMed ID: 9225706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study.
    Dal Maso L; Franceschi S; Lise M; De' Bianchi PS; Polesel J; Ghinelli F; Falcini F; Finarelli AC;
    BMC Cancer; 2010 Jun; 10():310. PubMed ID: 20565935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV incidence, pregnancy, and implementation outcomes from the Sakh'umndeni safer conception project in South Africa: a prospective cohort study.
    Schwartz SR; Bassett J; Mutunga L; Yende N; Mudavanhu M; Phofa R; Sanne I; Van Rie A
    Lancet HIV; 2019 Jul; 6(7):e438-e446. PubMed ID: 31160268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations.
    Gaym A; Mashego M; Kharsany AB; Walldorf J; Frohlich J; Karim QA
    S Afr Med J; 2007 Feb; 97(2):120-3. PubMed ID: 17404673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer screening in women living with HIV attending primary care clinics in a health district, South Africa: a descriptive cross-sectional study.
    Saasa-Modise ML; Musonda JM; Sikwese-Musonda J; Maseko NJ; Hlophe L; Kubeka G
    Pan Afr Med J; 2022; 43():32. PubMed ID: 36505015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.
    Luyten A; Scherbring S; Reinecke-Lüthge A; Braun BE; Pietralla M; Theiler K; Petry KU
    J Clin Virol; 2009 Nov; 46 Suppl 3():S5-10. PubMed ID: 20129072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of modifications to a human papillomavirus assay to optimise its utility for cervical cancer screening in low-resource settings: a diagnostic accuracy study.
    Kuhn L; Saidu R; Boa R; Tergas A; Moodley J; Persing D; Campbell S; Tsai WY; Wright TC; Denny L
    Lancet Glob Health; 2020 Feb; 8(2):e296-e304. PubMed ID: 31981559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Audit of cervical cancer screening and colposcopy attendance in rural South Africa.
    Knegt Y
    Afr J Reprod Health; 2014 Dec; 18(4):70-8. PubMed ID: 25854095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rural Zulu women's knowledge of and attitudes towards Pap smears and adherence to cervical screening.
    Godfrey MAL; Mathenjwa S; Mayat N
    Afr J Prim Health Care Fam Med; 2019 Oct; 11(1):e1-e6. PubMed ID: 31588773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clients' experiences utilizing a safer conception service for HIV affected individuals: implications for differentiated care service delivery models.
    Schwartz S; Davies N; Naidoo N; Pillay D; Makhoba N; Mullick S
    Reprod Health; 2019 May; 16(Suppl 1):65. PubMed ID: 31138252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing a Fee-for-Service Cervical Cancer Screening and Treatment Program in Cameroon: Challenges and Opportunities.
    DeGregorio G; Manga S; Kiyang E; Manjuh F; Bradford L; Cholli P; Wamai R; Ogembo R; Sando Z; Liu Y; Sheldon LK; Nulah K; Welty T; Welty E; Ogembo JG
    Oncologist; 2017 Jul; 22(7):850-859. PubMed ID: 28536303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
    Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
    PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study.
    Segondy M; Kelly H; Magooa MP; Djigma F; Ngou J; Gilham C; Omar T; Goumbri-Lompo O; Michelow P; Doutre S; Clavero O; Chikandiwa A; Sawadogo B; Didelot MN; Costes V; Méda N; Delany-Moretlwe S; Mayaud P
    Br J Cancer; 2016 Aug; 115(4):425-30. PubMed ID: 27434037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.